Medicine
-
IVF hormones could be delivered with painless 'microneedle' patch someday, early study hintsScientists are developing a microneedle patch that they hope could someday simplify IVF hormone delivery. They've tested it in animals.
By Theresa Sullivan Barger Published
-
Antibiotic resistance is the 'silent pandemic' — here are four steps to stop itFour major trends that will shape how we as a society will confront antibiotic resistance in the coming decade.
By André O. Hudson Published
-
Wegovy now comes in pill form — here's how it worksThe pill version of Wegovy seems to work just as well as the injectable form, but there are some key differences between the two formulations, experts say.
By Clarissa Brincat Published
-
Metal compounds identified as potential new antibiotics, thanks to robots doing 'click chemistry'Using robots and click chemistry, scientists built potential active ingredients for future antibiotics that contain metal.
By Victoria Atkinson Published
-
US government overhauls the childhood vaccine schedule in unprecedented moveFederal health officials are attempting to make the U.S. childhood vaccine schedule more like that of Denmark. Experts say the decision lacks scientific backing.
By Nicoletta Lanese Published
-
New drug could prevent diabetes complications not fixed with blood sugar control, study hintsAn experimental drug compound could be a promising treatment for harmful diabetes complications, per a new study in lab mice and human cells.
By Nicoletta Lanese Published
8 Comments -
New antivenom works against 17 dangerous African snake species, study suggestsScientists have developed a nanobody-based antivenom that neutralizes toxins from most African cobras, mambas and the rinkhals, which could offer safer, scalable protection beyond existing snakebite treatments.
By Sayan Tribedi Published
-
Newfound antibiotic shows '100 times' more potency against drug-resistant bacteria than its predecessorScientists have discovered a never-before-seen antibiotic that shows promising in treating drug-resistant infections.
By Victoria Atkinson Published
-
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on itThe U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of uncertainty, scientists worry that revolutionary treatments for cancer, immune dysfunction and genetic disease may be left on the lab bench.
By Nicoletta Lanese Published
6 Comments
